Quality Starts with the Raw Material
The quality of the starting hyaluronic acid is an important component of the manufacturing process.
Parameters such as purity, molecular characteristics and microbiological quality can influence the properties of the final formulation.
A controlled manufacturing process therefore begins with appropriate raw-material specifications.
Cross-Linking and Formulation
During the manufacturing process, HA may undergo cross-linking to create a more stable three-dimensional network.
The degree of modification and processing conditions influence the characteristics of the resulting gel.
However, quality cannot be assessed through cross-linking alone.
Purification
Following cross-linking, purification processes are important for removing unreacted substances and manufacturing-related impurities.
For cross-linked HA fillers, control of residual cross-linking agent is an important quality consideration.
Microbiological Quality
Dermal fillers are injectable medical products. Therefore, microbiological quality and control of endotoxin levels are important aspects of manufacturing and quality assurance.
Appropriate specifications and validated manufacturing processes are required to control these parameters.
Physical and Rheological Characterization
The final product can be characterized through multiple analytical parameters, including:
HA concentration
Rheological properties
Gel structure
Particle or phase characteristics
Injectability
pH and osmolality
Residual substances
Microbiological parameters
The specific tests and acceptance criteria depend on the product and applicable regulatory requirements.
Quality Management Systems
Medical-device manufacturing requires a structured quality management system covering manufacturing processes, documentation, traceability, risk management and quality control.
ISO 13485 is an internationally recognized standard for quality management systems for medical devices.
Key Takeaway
The quality of an HA dermal filler is the result of an integrated manufacturing and quality-control system—not a single material property. From raw material selection through final-product testing, each stage contributes to the consistency and quality of the finished product.
References
Manufacturing Process of Hyaluronic Acid Dermal Fillers. 2024.
Impurities in Hyaluronic Acid Dermal Fillers? A Narrative Review on Nonanimal Cross-Linked Fillers. 2024.
ISO 13485:2016 — Medical devices — Quality management systems — Requirements for regulatory purposes
2-
